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344a Monday, February 4, 2013enhanced with 2H-labeled Leu, due to the longer side chain of Leu when com-
pared to Val. Furthermore, 2H-labeled Ala can also be used with this technique.
This ESSEM secondary structural approach can be used with different deuter-
ated amino acids and provide pertinent qualitative structural information on
membrane proteins in a short period of time with small amounts of sample.
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Using spin labeling for studying protein macromolecules may reveal their sig-
nificant dynamical and structural properties. EPR spectrum contains informa-
tion about protein dynamics and internal motions, but, unfortunately, these
are extremely versatile, and spectrum present only ‘digest’ of it. There is is
an attractive way of joining Molecular Dynamics (MD) simulation with
EPR. MD provides detailed system dynamics, and number of attempts has
been made to calculate spectra directly from trajectory data. Still there is no
currently reliable algorithm developed to date for this purpose.
In this work, the study of complex formation between RNAse Barnase (Bn) and
its specific inhibitor Barstar (Bs), is presented. High affinity of Bs to Bn, this
protein pair is promising for creating large superstructures with controllable
properties. Mutant C40A barstar labeled by C82 with 4-(2-chloromercuri-
phenyl)-2,2,5,5-tetramethyl-3-imidazoline-D3-1-oxyl, as well as its complex
with Bn, was previously studied by X-band EPR to obtain correlation times
for macromolecule Brownian diffusion and order parameters for internal
dynamics.
We built a model of labeled Bs, and BsBn complex, and ran a number of full-
atom MD simulations. Both MD and EPR revealed two motional states of the
spin label, one highly ordered, and another flexible in free Barstar. Detailed
analysis of calculated data showed that difference between these two states
was solely due to internal dynamics of the protein. Corresponding azimuthal
order parameters calculated from MD trajectories well coincided with experi-
mental ones, obtained from EPR spectra. It was found that formation of BsBn
complex leads to complete disappearance of disordered state. Experimental ev-
idence (provided by spin labeling) of key features observed in MD trajectories
provide a validation of used parameters and protocols therefore.
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KCNE1 is a single transmembrane protein that modulates the activity of volt-
age gated potassium channels. KCNE1 interacts with KCNQ1 and decreases
the rate of channel activation, increases conductance, and generates a slowly
activating Kþ current critical for cardiac repolarization. Mutations on either
KCNE1 or KCNQ1 genes in E1/Q1 complex can lead to cardiac long QT syn-
drome. Despite the biological significance of the Q1/E1 interaction, its exact
nature is not fully understood yet. In this study, we have used different electron
paramagnetic resonance (EPR) spectroscopic techniques to provide the direct
evidence of binding activities of KCNQ1 with KCNE1. A CW-EPR titration
experiment was conducted on different sites in the C-terminus of KCNQ1
with the addition of WT-KCNE1 to determine the binding mechanism of Q1
and E1. The CW EPR line shape analysis indicates that the motion of the
spin label on Q1 decreases with the addition of WT-KCNE1 and saturates at
molar ratio of 1:3 (Q1:E1). Double electron-electron resonance (DEER) Spec-
troscopy was used to measure distances between the spin labels attached on E1
and Q1 separately in Q1/E1 complex. A DEER distance of 33 A˚ was obtained
between the spin labels at 318th position on Q1 and 106th position on E1 that
provides the direct evidence of formation of a Q1 and E1 complex. These EPR
techniques are very useful for determining the structural model of the Q1/E1
complex.
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University of Campinas (UNICAMP), Campinas, Brazil.Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) are
innovative alternatives in nanoencapsulation with a wide potential for con-
trolled drug release. Dibucaine (DBC) is a potent long-acting local anesthetics
but it is also toxic to the central nervous system. The purpose of this work was
to produce SLN and NLC formulations at pH 7.4 - composed by myristyl myr-
istate (MM) or MM / myglyol in their lipid matrices, respectively, plus Plur-
onic F68 - for DBC delivery, aiming a future application for pain control in the
skin. The lipid particles were characterized by nanoparticle tracking analysis
(NTA) and electron paramagnetic resonance (EPR) with nitroxide spin probes.
The size of SLN and NLC loaded with DBC were 175.67510.69 and 170.675
3.79nm, respectively; no significant changes were detected after DBC addition
(p% 0.05, unpaired t-test). Size distribution, given by the Span value, was kept
below 1, as expected for homogeneous dispersed colloids. EPR spectra of nitro-
xide probes revealed that dibucaine insertion into the nanoparticles below the
fusion temperature of MM increased lipid packing (ihþ1/h0 height ratio) while
the opposite (hhþ1/h0) occurs at 55oC. Moreover, the partition of DBC into
SLN/NLC seems to be a stable process since no hysteresis was observed after
a few heating/cooling cycles. In conclusion, we successfully prepared SLN and
NLC particles containing DBC which, in turn affects their structural properties.
Supported by FAPESP (# 06/00121-9) and CAPES (Brazil).
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Dibucaine (DBC) belongs to the amino amide family of local anesthetics. Un-
like other anesthetic compounds it possesses a rigid, butyl substituted, quino-
linic ring that imposes restrictions to its interaction with membranes. Solid
Lipid Nanoparticles (SLN) has been attracting attention as a promising drug de-
livery system because it combines advantages such as versatility, use of safe
excipients, a wide potential for the controlled drug release of drugs and good
shelf stability. The aim of this study was to develop SLN prepared with cetyl-
palmitate (CP) as the lipid matrix and poloxamer 188 as a colloidal stabilizer to
encapsulate DBC. Nanoparticles were prepared with the high pressure hot ho-
mogenization method and characterized by transmission electron microscopy
(TEM), small-angle X-ray scattering (SAXS) and electron paramagnetic reso-
nance (EPR). The association constant or partition coefficient was measured
(177.025 6.31). TEM images disclosure structures with delineated spherical
surfaces and homogenous size distribution (ca. 250-300 nm), in good agree-
ment with photon correlation spectroscopy data; incorporation of DBC did
not change the morphology and size of the nanoparticles. SAXS data showed
that the lipids in the SLN are organized in a liquid crystal-like structure,
with small amounts of water inside it (the same results were observed in the
SLN loaded with DBC). EPR spectra of 5-nitroxyl stearic acid incorporated
into SLN were compatible with SAXL data and revealed that dibucaine inser-
tion into the nanoparticles changed the lipid packing sensed by the spin label,
decreasing its isotropic signal. In conclusion we have shown that DBC can be
successfully incorporated into SLN, changing its lipid packing without destabi-
lizing the overall nanoparticle structure, indicating that this is a promising drug
delivery system. Supported by FAPESP (# 06/00121-9), CAPES, CNPq.
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The fluorescence dynamic Stokes shift(FDSS)ofW43 in themodel protein GB1,
was measured in both picosecond and nanosecond time domains by combining
Fluorescence Upconversion with Time Correlated Single Photon Counting
(TCSPC). We examined a wide range of pH values (from 8 to 3) where GB1
is known from NMR to be stable. We observe large changes in the nanosecond
lifetimes and DAS; Trp lifetime declines with reduced pH, likely due to differ-
ences in the Trp charge environment. Stern-Volmer plots revealed changes in
Trp exposure. In the picosecond domain, however, a characteristic risetime of
30 ps was seen for GB1 at 375nm. This negative amplitude remains constant
